A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

  1. Vincenti, F.
  2. Fervenza, F.C.
  3. Campbell, K.N.
  4. Diaz, M.
  5. Gesualdo, L.
  6. Nelson, P.
  7. Praga, M.
  8. Radhakrishnan, J.
  9. Sellin, L.
  10. Singh, A.
  11. Thornley-Brown, D.
  12. Veronese, F.V.
  13. Accomando, B.
  14. Engstrand, S.
  15. Ledbetter, S.
  16. Lin, J.
  17. Neylan, J.
  18. Tumlin, J.
Revue:
Kidney International Reports

ISSN: 2468-0249

Année de publication: 2017

Volumen: 2

Número: 5

Pages: 800-810

Type: Article

DOI: 10.1016/J.EKIR.2017.03.011 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus